Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$349M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$305M |
| 3 |
iShares Gold Trust
IAU
|
+$282M |
| 4 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$269M |
| 5 |
Blackrock
BLK
|
+$267M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$625M |
| 2 |
NVIDIA
NVDA
|
+$604M |
| 3 |
Tesla
TSLA
|
+$576M |
| 4 |
Microsoft
MSFT
|
+$552M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$357M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 40.73% |
| 2 | Technology | 20.55% |
| 3 | Financials | 7.82% |
| 4 | Consumer Discretionary | 7.64% |
| 5 | Communication Services | 5.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5176
Commercial Vehicle Group
CVGI
$114M
| $1.9K | ﹤0.01% |
1,144
-22,297
| -95% | -$27.1K |
2017 Q2
32 quarters
|
|
5177
iShares MSCI USA Equal Weighted ETF
EUSA
$1.88B
| $1.88K | ﹤0.01% |
19
-486
| -96% | -$45.6K |
2023 Q4
6 quarters
|
|
5178
Verrica Pharmaceuticals
VRCA
$64.4M
| $1.8K | ﹤0.01% |
340
-2,571
| -88% | -$13.8K |
2023 Q1
9 quarters
|
|
5179
Jefferson Capital
JCAP
$1.18B
| $1.75K | ﹤0.01% |
+95
| New | +$1.77K |
2025 Q2
0 quarters
|
|
5180
Twin Disc
TWIN
$361M
| $1.75K | ﹤0.01% |
198
-7,552
| -97% | -$55.8K |
2023 Q3
7 quarters
|
|
5181
NN Inc
NNBR
$321M
| $1.75K | ﹤0.01% |
832
-32,765
| -98% | -$65.3K |
2023 Q4
6 quarters
|
|
|
GSRT
5182
DELISTED
GSR III Acquisition Corp
GSRT
| $1.71K | ﹤0.01% |
+158
| New | +$1.65K |
2025 Q2
0 quarters
|
|
5183
Dorchester Minerals
DMLP
$1.49B
| $1.67K | ﹤0.01% |
60
| – | – |
2020 Q1
21 quarters
|
|
5184
FingerMotion
FNGR
$12.8M
| $1.66K | ﹤0.01% |
+818
| New | +$2.01K |
2025 Q2
0 quarters
|
|
5185
Forum Markets
FRMM
$49.6M
| $1.56K | ﹤0.01% |
165
+149
| +931% | +$1.46K |
2025 Q1
1 quarter
|
|
5186
The ONE Group
STKS
$42.1M
| $1.52K | ﹤0.01% |
375
-14,483
| -97% | -$49.8K |
2023 Q2
8 quarters
|
|
5187
DouYu International Holdings
DOYU
$107M
| $1.51K | ﹤0.01% |
233
-7,864
| -97% | -$53.2K |
2024 Q2
4 quarters
|
|
5188
Co-Diagnostics
CODX
$4.54M
| $1.51K | ﹤0.01% |
179
+169
| +1,690% | +$1.58K |
2025 Q1
1 quarter
|
|
5189
Allarity Therapeutics
ALLR
$13.1M
| $1.49K | ﹤0.01% |
+1,472
| New | +$1.39K |
2025 Q2
0 quarters
|
|
5190
TIM SA
TIMB
$8.73B
| $1.45K | ﹤0.01% |
72
-220
| -75% | -$3.76K |
2024 Q4
2 quarters
|
|
5191
X4 Pharmaceuticals
XFOR
$263M
| $1.45K | ﹤0.01% |
762
-3,317
| -81% | -$13.6K |
2023 Q2
8 quarters
|
|
|
OCFT
5192
DELISTED
OneConnect Financial Technology
OCFT
| $1.44K | ﹤0.01% |
200
| – | – |
2020 Q3
19 quarters
|
|
5193
DELISTED
Performance Technologies
PTIX
| $1.42K | ﹤0.01% |
+390
| New | +$1.5K |
2025 Q2
0 quarters
|
|
5194
Biomea Fusion
BMEA
$62.7M
| $1.35K | ﹤0.01% |
753
-19,470
| -96% | -$37.5K |
2021 Q2
16 quarters
|
|
5195
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.6B
| $1.34K | ﹤0.01% |
31
-19
| -38% | -$804 |
2022 Q1
13 quarters
|
|
5196
Culp Inc
CULP
$49M
| $1.32K | ﹤0.01% |
+335
| New | +$1.35K |
2025 Q2
0 quarters
|
|
5197
Veru
VERU
$40.4M
| $1.28K | ﹤0.01% |
220
-9,170
| -98% | -$51.5K |
2020 Q1
21 quarters
|
|
5198
Lineage Cell Therapeutics
LCTX
$247M
| $1.28K | ﹤0.01% |
1,406
-126,696
| -99% | -$75.2K |
2013 Q2
48 quarters
|
|
|
FLZH
5199
DELISTED
FLASH SPORTS & MEDIA HLDG
FLZH
| $1.28K | ﹤0.01% |
+170
| New | +$1.72K |
2025 Q2
0 quarters
|
|
5200
State Street SPDR S&P Oil & Gas Equipment & Services ETF
XES
$336M
| $1.27K | ﹤0.01% |
20
| – | – |
2013 Q2
48 quarters
|
|
Similar funds
Citigroup's Q2 2025 Portfolio in Review
As of Q2 2025, Citigroup held 6,003 positions worth $204B, up 4.1% from $196B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Citigroup's Q2 2025 filing shows 467 new, 1,653 increased, 2,974 reduced and 377 closed positions. Its largest new stake was Amrize Ltd: 2,294,135 shares worth $114M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $625M.
By sector, the portfolio is most concentrated in Miscellaneous at 41% of assets, down from 44% a quarter earlier, followed by Technology and Financials.
- Citigroup's largest Q2 2025 buy was Amrize Ltd: 2,294,135 shares worth $114M.
- Citigroup added most to Bank of America in Q2 2025, an estimated $349M increase.
- Citigroup's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $625M.
- Citigroup fully exited James Hardie Industries in Q2 2025, selling an estimated $125M.
- Citigroup's ten largest holdings make up 20% of its $204B portfolio in Q2 2025.
- Citigroup opened 467 new positions and closed 377 in Q2 2025.
- Citigroup's portfolio value rose 4.1% quarter-over-quarter to $204B.
Based on Citigroup's 13F filing for Q2 2025, filed 11 Aug 2025.